How We Saved $624.72 on Prescription Drugs

clipped from www.alzheimersreadingroom.com The FDA has granted special permission for two, five year old twins girls, to receive intravenous infusions of 2-Hydroxypropyl-beta-Cyclodextrin (also known as HPBCD). The girls received the go ahead for the treatment after a "compassionate use" exception was granted. The girls are suffering from Niemann Pick Type C disease, a fatal cholesterol metabolism disorder that is often referred to as the "Childhood Alzheimer’s".